This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Takashi Tomimatsu: Innovator in Pharmaceutical Composition
Introduction
Takashi Tomimatsu is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug solubility. With a total of 2 patents to his name, his work is recognized for its innovative approach to pharmaceutical formulations.
Latest Patents
Tomimatsu's latest patents focus on the preparation of tetracyclic compounds at high doses. His work emphasizes an improved solubility of pharmaceutical compositions containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or its salts. The innovative method involves forming granules of the compound or salt and allowing these granules to be present with a disintegrating agent, which enhances the solubility of the formulation.
Career Highlights
Tomimatsu is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His work at Chugai has allowed him to focus on advancing pharmaceutical technologies and improving drug delivery systems. His contributions have been instrumental in developing effective treatments that address various medical needs.
Collaborations
Throughout his career, Tomimatsu has collaborated with several talented individuals, including Kensuke Okazaki and Takahiro Yamamura. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Takashi Tomimatsu's work in pharmaceutical compositions showcases his dedication to improving drug solubility and efficacy. His innovative patents and collaborations highlight his significant role in advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
